Printer Friendly

I-FLOW TO REPORT $1.6 MILLION IN REVENUES FOR THE THIRD QUARTER OF 1993, A 169 PERCENT INCREASE OVER THE SAME PERIOD IN THE PRIOR YEAR

 IRVINE, Calif., Oct. 21 /PRNewswire/ -- I-FLOW Corp. (NASDAQ: IFLO), manufacturer and seller of innovative ambulatory infusion devices, today announced that revenues for the third quarter ended Sept. 30, 1993, exceeded $1.6 million. This represents an increase of more than 169 percent over the year-ago quarter and the fifth consecutive quarter of growth. The reported net loss for the quarter ended Sept. 30, 1993, will be approximately $631,000, or $0.11 per share, as compared to a net loss of $812,000, or $0.14 per share, in the year-ago quarter.
 For the nine months ended Sept. 30, 1993, revenues exceeded $4.4 million, an increase of 291 percent over the year-ago period. The company will report a net loss of approximately $2.0 million, or $0.34 per share, for the nine-month period as compared to a net loss of $2.8 million, or $0.59 per share, in the year-ago period.
 "With the results now in for the third quarter, we are well positioned to reach $6.0 million in revenues for calendar year 1993. If achieved, this will represent a significant increase over our original revenue projection of $5.0 million," said Donald M. Earhart, president and chief executive officer. "When you consider the expected contribution from the recently introduced Paragon -- our new low-cost infusion pump for pain medications and chemotherapy, along with the growth we are experiencing from our existing products, we are confident about I-FLOW's opportunities for future growth."
 I-FLOW Corp. designs, develops, manufacturers, and markets technically advanced ambulatory infusion systems uniquely well suited to the alternate care environment. Reliable, efficient, and easy-to-use, I-FLOW products offer users substantial opportunities to expand their therapy base, improve quality of care, and increase productivity. These advantages translate into improved revenues and profits for health care providers while reducing costs and improving the quality of life for patients.
 I-FLOW CORP.
 Statements of Operation
 (Unaudited; All amounts in thousands except per share amounts)
 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 1993 1992 1993 1992
 Revenues:
 Net sales $1,610 $464 $4,190 $755
 Rental income 37 129 183 335
 Interest income 9 22 34 37
 Total revenues 1,656 615 4,407 1,127
 Costs and expenses:
 Cost of sales 983 445 2,611 896
 Selling, general and
 administrative 912 771 2,762 2,341
 Research and
 development 392 211 1,028 660
 Total costs and
 expenses 2,287 1,427 6,401 3,897
 Net loss ($631) ($812) ($1,994) ($2,770)
 Net loss per share ($0.11) ($0.14) ($0.34) ($0.59)
 Weighted average
 number of common
 shares outstanding 5,896 5,699 5,896 4,701
 -0- 10/21/93
 /CONTACT: Jim Dal Porto, executive VP, 714-553-0888/
 (IFLO)


CO: I-FLOW Corp. ST: California IN: HEA SU: ERN

LM-LS -- LA011 -- 5046 10/21/93 10:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1993
Words:474
Previous Article:OUTBACK STEAKHOUSE, INC. REPORTS 71 PERCENT INCREASE IN THIRD QUARTER EARNINGS
Next Article:AZTAR REPORTS 3RD QUARTER 1993 RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters